2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 219.820 | 160.261 | 224.936 | 76.947 | 87.095 | 68.676 | 15.285 | 15.585 | 15.694 | 15.701 |
Total Income - EUR | 220.553 | 160.607 | 225.849 | 77.219 | 87.556 | 68.716 | 20.077 | 15.841 | 15.997 | 31.485 |
Total Expenses - EUR | 207.063 | 144.973 | 110.205 | 60.138 | 63.802 | 53.215 | 15.310 | 5.926 | 5.503 | 29.092 |
Gross Profit/Loss - EUR | 13.490 | 15.633 | 115.644 | 17.081 | 23.754 | 15.502 | 4.768 | 9.915 | 10.495 | 2.393 |
Net Profit/Loss - EUR | 11.284 | 13.132 | 93.473 | 14.581 | 21.119 | 13.440 | 4.166 | 9.439 | 10.024 | 542 |
Employees | 4 | 4 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ana Sinfarm S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 43.741 | 38.412 | 34.122 | 28.721 | 27.360 | 21.588 | 45.369 | 44.277 | 43.628 | 48.683 |
Current Assets | 118.600 | 109.165 | 95.972 | 22.564 | 33.471 | 19.667 | 1.111 | 2.768 | 394 | 284 |
Inventories | 23.645 | 14.334 | 185 | 153 | 150 | 141 | 105 | 103 | 103 | 103 |
Receivables | 60.717 | 79.754 | 58.473 | 22.363 | 19.642 | 11.359 | 567 | 16 | 12 | 12 |
Cash | 32.993 | 15.076 | 37.313 | 48 | 13.679 | 8.167 | 438 | 2.649 | 279 | 169 |
Shareholders Funds | 43.444 | 56.939 | 121.793 | 42.421 | 58.034 | 40.368 | 30.458 | 39.920 | 43.376 | 36.610 |
Social Capital | 446 | 450 | 445 | 438 | 430 | 421 | 413 | 404 | 406 | 404 |
Debts | 118.897 | 90.917 | 8.449 | 9.059 | 2.901 | 989 | 16.048 | 7.126 | 646 | 12.357 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Ana Sinfarm S.r.l.